BPA for illuccix

Active Awarded Last action

Contract number
36E79722A0025
Awardee
Awarding agency
Task orders
2 $2,891,800 obligated

Award facts

Opportunity
  • VA797P12Q0002 Solicitation number
Combined order value
$2,891,800 Current and potential, with all options
Last date to order 83% complete
IDV ceiling 17% used
$17,500,000.00
Award type
Single award
Who can order
Only the awarding agency
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

About this IDV

The VA National Acquisition Center established a Blanket Purchase Agreement with Telix Pharmaceuticals US Inc. on August 30, 2022, with a $17.5 million ceiling and ultimate completion date of August 29, 2027, for supply of Illuccix, a radiopharmaceutical imaging agent for prostate cancer diagnostic procedures.

The BPA is established against the GSA Federal Supply Schedule for Pharmaceuticals and Drugs (FSS-61-IB). Work is performed at Telix's facilities in Fishers, Indiana, with secondary performance locations in Dublin, Ohio and Norcross, Georgia.

Recent BPA-call activity under this vehicle includes a $1.75 million firm fixed-price call issued by Veterans Integrated Service Network 8 on October 1, 2025, for Illuccix supply with completion by September 30, 2026, and a $1,141,800 call from the same network awarded October 1, 2024, with completion by September 30, 2025. Both calls carry firm fixed-price pricing and are performed at Telix's Fishers, Indiana location.

Task orders

Task order Ordering agency Obligated Awarded
Illuccix 36C24826N0054 Veterans Integrated Service Network 8 (VHA) $1,750,000
Illuccix 36C24825N0060 Veterans Integrated Service Network 8 (VHA) $1,141,800

Transactions

Action Obligated Date
Exercise an Option P00010 · Exercise option year 4 - BPA 36E79722A0025 $0
Supplemental Agreement for work within scope P00009 · 2026 public law pricing updates. $0
Supplemental Agreement for work within scope P00008 · Temporary price reduction - illuccix $0
Exercise an Option P00007 · Exercise option year 3 $0
Supplemental Agreement for work within scope P00006 · 2025 public law pricing updates $0
Exercise an Option P00005 · Exercise option year 2 $0
Supplemental Agreement for work within scope P00004 · Illuccix TPR $0
Supplemental Agreement for work within scope P00003 · 2024 public law pricing updates $0
Exercise an Option P00002 · Exercise the 1ST option year on BPA 36E79722A0025 $0
Supplemental Agreement for work within scope P00001 · Temporary price reduction - illuccix $0
Original award $0
Show all 11

Quick answers

Who was awarded contract 36E79722A0025?

36E79722A0025 was awarded to Telix Pharmaceuticals US Inc. by National Acquisition Center (Headquarters) on August 30, 2022.

How much is contract 36E79722A0025 worth?

Orders under 36E79722A0025 have obligated $2,891,800. 36E79722A0025's own ceiling is $17,500,000.

How many orders have been placed under contract 36E79722A0025?

2 orders have been placed under 36E79722A0025, the latest on October 1, 2025.

Who can order from contract 36E79722A0025?

36E79722A0025 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.

Is contract 36E79722A0025 under another contract?

Yes. 36E79722A0025 is a blanket purchase agreement under 36F79722D0197, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36E79722A0025 competed?

The extent of competition for 36E79722A0025 was full and open competition. The government received 1 offer.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV